Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review

SIMPLE SUMMARY: For decades, there has been no globally accepted neoadjuvant or adjuvant therapy in resectable biliary tract cancer. Based on the results of the BILCAP trial, adjuvant capecitabine has been widely regarded as standard adjuvant therapy. Focusing on the management of resectable biliary...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancers (Basel)
Päätekijät: Yoo, Changhoon, Shin, Sang Hyun, Park, Joon-Oh, Kim, Kyu-Pyo, Jeong, Jae Ho, Ryoo, Baek-Yeol, Lee, Woohyung, Song, Ki-Byung, Hwang, Dae-Wook, Park, Jin-hong, Lee, Jae Hoon
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2021
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8037230/
https://ncbi.nlm.nih.gov/pubmed/33916008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071647
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia